ctSearch Results
Original Query
AIDS - What is Conference Retroviruses
Search Results
Preview
(ritonavir)-boosted Reyataz (atazanavir) is more likely to contribute to bone loss than Sustiva (efavirenz), according to new data from the AIDS Clinical Trials Group (ACTG) reported Thursday, February 18, at the 17th Conference on Retroviruses and Opportunistic Infections in San Francisco
For more information on each topic click the link(s) above.
ContactWeb : http://c-t-search.info
E-mail : E-Mail
Search Engine : c-t-search.appspot.com
ctMedBrowser : More ctMedBrowser Info
Sponsor : Peta Software Promo


No comments:
Post a Comment